Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
暂无分享,去创建一个
[1] S. Joshua Swamidass,et al. Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. , 2015, Chemical research in toxicology.
[2] Pierre Baldi,et al. Deep autoencoder neural networks for gene ontology annotation predictions , 2014, BCB.
[3] Lars Olsen,et al. Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactions. , 2014, Journal of molecular graphics & modelling.
[4] C. Ramasamy,et al. COMPARISION OF EFFICACY AND SAFETY OF CARBAMAZEPINE AND ESLICARBAZEPINE IN ADULT PARTIAL AND GENERALIZED SEIZURES , 2014 .
[5] M. Pirmohamed,et al. Covalent adduction of carbamazepine 10, 11-epoxide with human serum albumin and glutathione S-transferase pi: implications for carbamazepine hypersensitivity , 2014, The Lancet.
[6] Sanjay Joshua Swamidass,et al. XenoSite: Accurately Predicting CYP-Mediated Sites of Metabolism with Neural Networks , 2013, J. Chem. Inf. Model..
[7] D. Lamb,et al. Streptomyces cytochromes P450: applications in drug metabolism , 2013, Expert opinion on drug metabolism & toxicology.
[8] Tara N. Sainath,et al. Deep convolutional neural networks for LVCSR , 2013, 2013 IEEE International Conference on Acoustics, Speech and Signal Processing.
[9] Pavel Hobza,et al. On the performance of the semiempirical quantum mechanical PM6 and PM7 methods for noncovalent interactions , 2013 .
[10] Paolo Benedetti,et al. Exposition and reactivity optimization to predict sites of metabolism in chemicals. , 2013, Drug discovery today. Technologies.
[11] Valérie Campagna-Slater,et al. Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s , 2012, J. Chem. Inf. Model..
[12] Alessandro Pedretti,et al. Reactions and enzymes in the metabolism of drugs and other xenobiotics. , 2012, Drug discovery today.
[13] Kristin P. Bennett,et al. RS-Predictor Models Augmented with SMARTCyp Reactivities: Robust Metabolic Regioselectivity Predictions for Nine CYP Isozymes , 2012, J. Chem. Inf. Model..
[14] F. Guengerich,et al. Contributions of human enzymes in carcinogen metabolism. , 2012, Chemical research in toxicology.
[15] D. Amacher. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury , 2012, Expert opinion on drug metabolism & toxicology.
[16] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[17] A. Stepan,et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. , 2011, Chemical research in toxicology.
[18] J. Harder,et al. Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose , 2011, Hemodialysis international. International Symposium on Home Hemodialysis.
[19] Ian D. Wilson,et al. Managing the challenge of chemically reactive metabolites in drug development , 2011, Nature Reviews Drug Discovery.
[20] B. Fromenty,et al. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. , 2011, Journal of hepatology.
[21] Q. Ning,et al. Acute liver failure: mechanisms of immune‐mediated liver injury , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[22] S. Attia. Deleterious effects of reactive metabolites , 2010, Oxidative medicine and cellular longevity.
[23] Pierre Baldi,et al. A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval , 2010, Bioinform..
[24] R. El-Mallakh,et al. Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures , 2010, Therapeutics and clinical risk management.
[25] David E. Gloriam,et al. SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. , 2010, ACS medicinal chemistry letters.
[26] Q. Zeng,et al. Cytochrome P450-mediated epoxidation of 2-aminothiazole-based AKT inhibitors: identification of novel GSH adducts and reduction of metabolic activation through structural changes guided by in silico and in vitro screening. , 2010, Chemical research in toxicology.
[27] Dominic P. Williams,et al. Quantifying the Metabolic Activation of Nevirapine in Patients by Integrated Applications of NMR and Mass Spectrometries , 2010, Drug Metabolism and Disposition.
[28] R. Steenwyk,et al. In vitro evidence for the formation of reactive intermediates of resveratrol in human liver microsomes , 2010, Xenobiotica; the fate of foreign compounds in biological systems.
[29] Vijay T. Ahuja,et al. Comparative Biotransformation of Pyrazinone-Containing Corticotropin-Releasing Factor Receptor-1 Antagonists: Minimizing the Reactive Metabolite Formation , 2010, Drug Metabolism and Disposition.
[30] A. Kalgutkar,et al. Structural Alerts, Reactive Metabolites, and Protein Covalent Binding: How Reliable Are These Attributes as Predictors of Drug Toxicity? , 2009, Chemistry & biodiversity.
[31] Yuan Chen,et al. Revisiting the metabolism of ketoconazole using accurate mass. , 2009, Drug metabolism letters.
[32] Chang-Joon Lee,et al. EaMEAD: Activation Energy Prediction of Cytochrome P450 Mediated Metabolism with Effective Atomic Descriptors , 2009, J. Chem. Inf. Model..
[33] R Scott Obach,et al. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. , 2008, Chemical research in toxicology.
[34] Chris Morley,et al. Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit , 2008, Chemistry Central journal.
[35] Wei Tang. Drug metabolite profiling and elucidation of drug-induced hepatotoxicity , 2007, Expert opinion on drug metabolism & toxicology.
[36] M. Kubo,et al. Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1 , 2007, The Journal of Immunology.
[37] S. Amin,et al. Investigation of the genotoxicity of dibenzo[c,p]chrysene in human carcinoma MCF-7 cells in culture. , 2006, Chemico-biological interactions.
[38] J. Leeder,et al. PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE , 2005, Drug Metabolism and Disposition.
[39] N. Kaplowitz,et al. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. , 2005, Toxicology and applied pharmacology.
[40] S. Amin,et al. Human cytochromes P450 1A1 and 1B1 catalyze ring oxidation but not nitroreduction of environmental pollutant mononitropyrene isomers in primary cultures of human breast cells and cultured MCF-10A and MCF-7 cell lines. , 2004, Chemical research in toxicology.
[41] Paul A. Smith,et al. Comparison of Linear and Nonlinear Classification Algorithms for the Prediction of Drug and Chemical Metabolism by Human UDP-Glucuronosyltransferase Isoforms , 2003, J. Chem. Inf. Comput. Sci..
[42] Gabriele Cruciani,et al. Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.
[43] Simon C Watkins,et al. Role of glutathione conjugate efflux in cellular protection against benzo[a]pyrene‐7,8‐diol‐9,10‐epoxide–induced DNA damage , 2002, Molecular carcinogenesis.
[44] F. Guengerich,et al. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.
[45] M. Kalis,et al. Oxcarbazepine, an antiepileptic agent. , 2001, Clinical therapeutics.
[46] C J Omiecinski,et al. Epoxide hydrolases: biochemistry and molecular biology. , 2000, Chemico-biological interactions.
[47] S. Knowles,et al. Idiosyncratic drug reactions: the reactive metabolite syndromes , 2000, The Lancet.
[48] Andrew Hunter,et al. Application of neural networks and sensitivity analysis to improved prediction of trauma survival , 2000, Comput. Methods Programs Biomed..
[49] A. Namera,et al. Automated preparation and analysis of barbiturates in human urine using the combined system of PrepStation and gas chromatography-mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[50] J. Seidegård,et al. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. , 1997, Environmental health perspectives.
[51] B. Hammock,et al. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.
[52] J. Dawson,et al. Heme-Containing Oxygenases. , 1996, Chemical reviews.
[53] M. Pirmohamed,et al. Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. , 1995, Biochemical pharmacology.
[54] J. DiMasi,et al. Success rates for new drugs entering clinical testing in the United States , 1995, Clinical pharmacology and therapeutics.
[55] H. Bartsch,et al. Anti-benzo[a]pyrene diolepoxide--DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. , 1995, Carcinogenesis.
[56] James J. P. Stewart,et al. MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..
[57] T. C. Bruice,et al. Intermediates in the epoxidation of alkenes by cytochrome P-450 models. 5. Epoxidation of alkenes catalyzed by a sterically hindered (meso-tetrakis(2,6-dibromophenyl)porphinato)iron(III) chloride , 1989 .
[58] Y. Løyning,et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy , 1989, Epilepsy Research.
[59] J R Gillette,et al. The role of biotransformation in chemical-induced liver injury. , 1976, Environmental health perspectives.
[60] K. Alton,et al. Biotransformation of a 1,5-benzodiazepine, triflubazam, by man. , 1975, Drug metabolism and disposition: the biological fate of chemicals.
[61] W. Whalley,et al. Metabolism of quinalbarbitone , 1975, The Journal of pharmacy and pharmacology.
[62] N. Isaacs,et al. Mechanisms Of Epoxide Reactions , 1959 .
[63] C. Morisseau. Role of epoxide hydrolases in lipid metabolism. , 2013, Biochimie.
[64] Zhiwen Zhang,et al. Investigation of piceid metabolites in rat by liquid chromatography tandem mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[65] D A Smith,et al. Role of reactive metabolites in drug-induced hepatotoxicity. , 2010, Handbook of experimental pharmacology.
[66] D. Galeone,et al. Acute hepatitis in a patient treated with carbamazepine , 2004, Journal of Neurology.
[67] F. Guengerich. Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. , 2003, Archives of biochemistry and biophysics.
[68] Michael M. Mysinger,et al. Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction. , 2002, Drug metabolism and disposition: the biological fate of chemicals.